Get started
Author

Sarah Kandoussi

Immune Checkpoint Inhibitors in Human Glioma Microenvironment
2021 · Amina Ghouzlani, Sarah Kandoussi, et al. · Frontiers in Immunology · 150
PDF
CAR T-cells for colorectal cancer immunotherapy: Ready to go?
2022 · Bouchra Ghazi, Adil El Ghanmi, et al. · Frontiers in Immunology · 47
PDF
Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches
2024 · Oumayma Naji, Amina Ghouzlani, et al. · Frontiers in Immunology · 21
PDF
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
2023 · Soumaya Rafii, Sarah Kandoussi, et al. · Frontiers in Oncology · 15
PDF
A2AR as a Prognostic Marker and a Potential Immunotherapy Target in Human Glioma
2023 · Soumaya Rafii, Amina Ghouzlani, et al. · International Journal of Molecular Sciences · 11
PDF
High Expression Levels of Foxp3 and VISTA in Advanced Human Gliomas and Impact on Patient’s Prognosis
2020 · Amina Ghouzlani, Sarah Kandoussi, et al. · Archives of Clinical and Biomedical Research · 6
Identification of Promising Antagonists of the Tumor Microenvironment Immunosuppressive Adenosine 2A Receptor through a Pharmacoinformatics- Based Approach
2021 · Soumaya Rafii, Yassine El Ghallab, et al. · Journal of Bioinformatics and Systems Biology · 2
Comparative Evaluation of Hematopoietic Stem Cell Cryopreservation Using Liquid Nitrogen Versus -80°C Storage
2026 · Zakaria El Kodmiri, Maryame Ahnach, et al. · Cureus
187 CD96: a new predictor of poor prognosis in advanced human gliomas
2025 · Zakia Harmak, Sarah Kandoussi, et al. · Journal for ImmunoTherapy of Cancer
PDF
Rutin: A Novel A2AR Antagonist with Promising Therapeutic Potential for Cancer Immunotherapy
2025 · Sarah Kandoussi, Soumaya Rafii, et al. · Journal of Bioinformatics and Systems Biology
Works count: 10
Citation count: 252
H-index: 6
I10-index: 5
Year
Topic
Type